In 2020, we reported that DEK loss in SH-SY5Y cells, isolated from a female patient and differentiated to neurons, resulted in AD phenotypes, such as cell death and Tau pathology (Greene et al., 2020). The gene discussed is MAPT; the disease is Alzheimer disease.